Prescrire Int. 2008 Feb;17(93):28-32.
(1) Seasonal allergic rhinitis, otherwise known as hayfever, is a harmless condition, although it can cause major discomfort and interfere with activities of daily living. We conducted a review of the literature, based on our in-house methodology, to determine the risk-benefits of treatments used in this setting. (2) Placebo-controlled trials show that sodium cromoglicate relieves symptoms, especially if it is used before symptoms appear. Adverse effects are rare with sodium cromoglicate nasal solutions and eye drops. (3) Nasal steroids have well-documented efficacy. Beclometasone is the best choice. Adverse effects include epistaxis, nasal irritation and, occasionally, systemic disorders. (4) Oral antihistamines are less effective than nasal steroids. They also provoke adverse effects, especially drowsiness. Nasal azelastine seems to have a similar efficacy as oral antihistamines. (5) The adverse effects of systemic steroids must not be overlooked, especially with long-term use. Oral administration is an alternative for severe symptoms that do not respond to other treatments, although this is rarely the case. Long-acting intramuscular steroids carry an increased risk of adverse effects. (6) Despite evaluation in several randomised controlled trials, there is no firm evidence that homeopathic preparations have any specific efficacy in allergic rhinitis. (7) Vasoconstrictors, ipratropium and montelukast, have negative risk-benefit balances in hay fever. (8) When a single allergen is responsible (grasses, ragweed, birch), clinical trials suggest that specific desensitisation can provide a modest improvement. However, this treatment carries a risk of local adverse effects, as well as a risk of rare but severe anaphylactic reactions, especially in patients who also have unstable severe asthma. (9) Sublingual desensitisation seems to be even less effective than subcutaneous desensitisation in adults. Follow-up is too short to know whether there is a risk of severe anaphylactic reactions. The results of paediatric studies are even less convincing. (10) In practice, when drug therapy is needed to relieve symptoms of seasonal allergic rhinitis, sodium cromoglicate is the first-line treatment. If a nasal steroid solution is chosen, it should be used for the shortest possible period.
(1)季节性变应性鼻炎,又称花粉症,虽不会造成严重后果,但会引起极大不适并影响日常生活。我们依据内部方法对文献进行了综述,以确定该病症治疗方法的风险与益处。(2)安慰剂对照试验表明,色甘酸钠可缓解症状,尤其是在症状出现前使用时。色甘酸钠滴鼻液和滴眼液的不良反应很少见。(3)鼻用类固醇的疗效有充分记录。倍氯米松是最佳选择。不良反应包括鼻出血、鼻刺激,偶尔还会出现全身紊乱。(4)口服抗组胺药的效果不如鼻用类固醇。它们也会引发不良反应,尤其是嗜睡。鼻用氮卓斯汀的疗效似乎与口服抗组胺药相似。(5)全身用类固醇的不良反应不容忽视,尤其是长期使用时。口服给药是对其他治疗无反应的严重症状的一种替代方法,不过这种情况很少见。长效肌肉注射类固醇的不良反应风险更高。(6)尽管经过了多项随机对照试验评估,但尚无确凿证据表明顺势疗法制剂对变应性鼻炎有任何特效。(7)血管收缩剂、异丙托溴铵和孟鲁司特在花粉症中的风险效益比为负。(8)当单一过敏原(草、豚草、桦树)致病时,临床试验表明特异性脱敏可带来一定改善。然而,这种治疗存在局部不良反应风险,以及罕见但严重的过敏反应风险,尤其是在患有不稳定重症哮喘的患者中。(9)在成人中,舌下脱敏似乎比皮下脱敏效果更差。随访时间过短,尚不清楚是否存在严重过敏反应风险。儿科研究结果更缺乏说服力。(10)在实际应用中,当需要药物治疗来缓解季节性变应性鼻炎症状时,色甘酸钠是一线治疗药物。如果选择鼻用类固醇溶液,应尽可能缩短使用时间。